Untitled Document

>[1996]-[1995]-[1994]<

Bouriquet N, Dupont M, Herizi A, Mimran A, Casellas D. Preglomerular sudanophilia in L-NAME-hypertensive rats: Involvement of endothelin. Hypertension 1996, 27 (part 1):382-391.

Casellas D, Carmines PK. Control of the renal microcirculation: Cellular and integrative perspectives. Current Opinion in Nephrology and Hypertension 1996, 5: 57-63.

Herizi A, Demeilliers B, Jover B, Mimran A. Cardioprotective effect of enalapril in renovascular and angiotensin II hypertension. Clin Experimental Hypertension (in press).

Jover B, Herizi A, Mimran A. Chronic kinin blockade and effect of ramipril in renal adaptation to sodium restriction. Hypertension 1996, 27:79-84.

Mimran A, Ribstein J, Du Cailar G, Halimi JM. Hyperfiltration in lean essential hypertension. Contrib Nephrol Basel, Karger, 1996, vol 119:98-102.

Mimran A, Ribstein J. Microalbuminuria in essential hypertension. J Human Hypertens 1996, 10:657-661.

Mimran A. Antihypertensive therapy and renal function. J Cardiovasc Pharmacol 1996, 27 (suppl 3):S19-S25.

Mimran A. How does prazosin GITS compare with nifedipine in hypertension? A randomised, comparative, parallel-group study. Indian Heart J 1996, 48 (suppl 1):23-26.

Van Lambalgen AA, Bouriquet N, Casellas D. Effects of endotoxin on tone and pressure-responsiveness of preglomerular juxtamedullary vessels. Pflügers Archiv 1996, 432 (3): 574-577.

Bouriquet N, Casellas D. Chronic L-NAME hypertension in rats and autoregulation of juxtamedullary preglomerular vessels. Am J Physiol 1995, 269 (Renal Fluid Electrolyte Physiol. 38): F190-F197.

Bouriquet N, Casellas D. Interaction between cGMP-dependent dilators and autoregulation in rat preglomerular vasculature. Am J Physiol 1995, 268 (Renal Fluid Electrolyte Physiol.37): F338-F346.

Corvol P, Pinet F, Plouin PF, Bruneval P, Gasc JM, Ménard J, Mimran A. Primary Reninism. In Hypertension : Pathophysiology, Diagnosis and Management (second Edition) Laragh JH, Brenner BM, Editors, Raven Press 1995, p.2069-2079.

Demeilliers B, Jover B, Mimran A. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan. J Hypertens 1995, 13:1764-1766.

Du Cailar G, Ribstein J, Mimran A. Left ventricular contractility and insulin resistance in essential hypertension. Blood Pressure 1995, 4:23-31.

Halimi JM, Mimran A. Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 1995, 13 (part 2):1801-1802.

Halimi JM, Ribstein J, Du Cailar G, Ennouchi JM, Mimran A. Albuminuria predicts renal functional outcome after intervention in atheromatous renovascular disease. J Hypertens 1995, 13:1335-1342.

Mimran A, Mourad G, Ribstein J, Halimi JM. Cyclosporine-associated hypertension. In Hypertension : Pathophysiology, Diagnosis and Management (second Edition) Laragh JH, Brenner BM, Editors, Raven Press 1995, p.2459-2469.

Mimran A, Ribstein J, Du Cailar G. Contrasting effect of antihypertensive treatment on the renal response to L-arginine. Hypertension 1995, 26(part 1):937-941.

Mourad G, Halimi JM, Ribstein J, Mimran A. Renal and renovascular hypertension. In Therapy of renal disease and related disorders. WN Suki & SG Massry eds, Kluwer Academic Publishers, Boston 1995 ( in Press).

Ribstein J, Du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 1995, 26:610-615.

Bertolino F, Valentin JP, Maffre M, Jover B, Bessac AM, John GW. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a non peptide angiotensin II type-1 (AT1) receptor antagonist. J Pharmacol Exp Ther 1994, 268: 747-752.

Casellas D, Bouriquet N. Nimodipine-resistant tone in myogenically active preglomerular arteries of rat kidneys. Acta Physiol Scand 1994, 152: 345-347.

Casellas D, Dupont M, Bouriquet N, Moore LC, Artuso A, Mimran A. Anatomic pairing of afferent arterioles and renin cell distribution in rat kidneys. American Journal of Physiology 1994, 267 (Renal Fluid Electrolyte Physiology 36):F931-F936.

Jover B, Mimran A. Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors : effects on renal function. Journal of Hypertension 1994, 12 (suppl 9):S3-S9.

Jover B, Saladini D, Nafrialdi N, Dupont M, Mimran A. Effect of losartan and enalapril on renal adaptation to sodium restriction in rat. American Journal of Physiology 1994, 267 (Renal Fluid Electrolyte Physiology 36):F281-F288.

Kupferman JC, Beaudoin R, Carr R, Hay D, Casellas D, Kaskel FJ, Moore LC. Activation of the renal renin-angiotensin system by Cyclosporine A and FK-506 in the rat. Transplant Proc 1994, 26: 2891-2893.

Mimran A, Ribstein J, Du Cailar G, Halimi JM. Albuminuria in normals and essential hypertension. Journal of Diabetes and its complications 1994;8:150-156.

Mimran A, Ribstein J, Du Cailar G. Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension ? Hypertension 1994, 23 (part 2):1018-1021.

Mimran A, Ribstein J. Angiotensin-converting enzyme inhibitors versus calcium antagonists in the progression of renal diseases. American Journal of Hypertension 1994, 7:73S-81S.

Mimran A. Renin-secreting tumours. In Textbook of Hypertension, Edited by JD Swales, Blackwell Scientific Publications 1994, p. 858-864.

Moore LC, Rich A, Casellas D. Ascending myogenic autoregulation: Interactions between tubuloglomerular feedback and myogenic mechanisms. Bull Math Biol 1994, 56: 391-410.

Nafrialdi N, Jover B, Mimran A. Endogenous vasoactive systems and the pressors effect of acute Nw-Nitro-L-Arginine Methyl ester administration. Journal of Cardiovascular Pharmacology 1994, 23:765-771.

Pasquié JL, Jover B, Du Cailar G, Mimran A. Sodium but not chloride ion modulates left ventricular hypertrophy in two-kidney, one clip hypertension. Journal of Hypertension 1994, 12:1013-1018.

Valentin JP, Ribstein J, Mimran A. Influence of Dopamine and Angiotensin II blockade on the acute response to unilateral nephrectomy in the rats. Journal of Cardiovascular Pharmacology 1994, 23:246-251.

	>[1996]-[1995]-[1994]<

	Bouriquet N, Dupont M, Herizi A, Mimran A, Casellas D. Preglomerular sudanophilia in L-NAME-hypertensive rats: Involvement of endothelin. Hypertension 1996, 27 (part 1):382-391. Casellas D, Carmines PK. Control of the renal microcirculation: Cellular and integrative perspectives. Current Opinion in Nephrology and Hypertension 1996, 5: 57-63. Herizi A, Demeilliers B, Jover B, Mimran A. Cardioprotective effect of enalapril in renovascular and angiotensin II hypertension. Clin Experimental Hypertension (in press). Jover B, Herizi A, Mimran A. Chronic kinin blockade and effect of ramipril in renal adaptation to sodium restriction. Hypertension 1996, 27:79-84. Mimran A, Ribstein J, Du Cailar G, Halimi JM. Hyperfiltration in lean essential hypertension. Contrib Nephrol Basel, Karger, 1996, vol 119:98-102. Mimran A, Ribstein J. Microalbuminuria in essential hypertension. J Human Hypertens 1996, 10:657-661. Mimran A. Antihypertensive therapy and renal function. J Cardiovasc Pharmacol 1996, 27 (suppl 3):S19-S25. Mimran A. How does prazosin GITS compare with nifedipine in hypertension? A randomised, comparative, parallel-group study. Indian Heart J 1996, 48 (suppl 1):23-26. Van Lambalgen AA, Bouriquet N, Casellas D. Effects of endotoxin on tone and pressure-responsiveness of preglomerular juxtamedullary vessels. Pflügers Archiv 1996, 432 (3): 574-577.

	Bouriquet N, Casellas D. Chronic L-NAME hypertension in rats and autoregulation of juxtamedullary preglomerular vessels. Am J Physiol 1995, 269 (Renal Fluid Electrolyte Physiol. 38): F190-F197. Bouriquet N, Casellas D. Interaction between cGMP-dependent dilators and autoregulation in rat preglomerular vasculature. Am J Physiol 1995, 268 (Renal Fluid Electrolyte Physiol.37): F338-F346. Corvol P, Pinet F, Plouin PF, Bruneval P, Gasc JM, Ménard J, Mimran A. Primary Reninism. In Hypertension : Pathophysiology, Diagnosis and Management (second Edition) Laragh JH, Brenner BM, Editors, Raven Press 1995, p.2069-2079. Demeilliers B, Jover B, Mimran A. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan. J Hypertens 1995, 13:1764-1766. Du Cailar G, Ribstein J, Mimran A. Left ventricular contractility and insulin resistance in essential hypertension. Blood Pressure 1995, 4:23-31. Halimi JM, Mimran A. Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 1995, 13 (part 2):1801-1802. Halimi JM, Ribstein J, Du Cailar G, Ennouchi JM, Mimran A. Albuminuria predicts renal functional outcome after intervention in atheromatous renovascular disease. J Hypertens 1995, 13:1335-1342. Mimran A, Mourad G, Ribstein J, Halimi JM. Cyclosporine-associated hypertension. In Hypertension : Pathophysiology, Diagnosis and Management (second Edition) Laragh JH, Brenner BM, Editors, Raven Press 1995, p.2459-2469. Mimran A, Ribstein J, Du Cailar G. Contrasting effect of antihypertensive treatment on the renal response to L-arginine. Hypertension 1995, 26(part 1):937-941. Mourad G, Halimi JM, Ribstein J, Mimran A. Renal and renovascular hypertension. In Therapy of renal disease and related disorders. WN Suki & SG Massry eds, Kluwer Academic Publishers, Boston 1995 ( in Press). Ribstein J, Du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 1995, 26:610-615.

	Bertolino F, Valentin JP, Maffre M, Jover B, Bessac AM, John GW. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a non peptide angiotensin II type-1 (AT1) receptor antagonist. J Pharmacol Exp Ther 1994, 268: 747-752. Casellas D, Bouriquet N. Nimodipine-resistant tone in myogenically active preglomerular arteries of rat kidneys. Acta Physiol Scand 1994, 152: 345-347. Casellas D, Dupont M, Bouriquet N, Moore LC, Artuso A, Mimran A. Anatomic pairing of afferent arterioles and renin cell distribution in rat kidneys. American Journal of Physiology 1994, 267 (Renal Fluid Electrolyte Physiology 36):F931-F936. Jover B, Mimran A. Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors : effects on renal function. Journal of Hypertension 1994, 12 (suppl 9):S3-S9. Jover B, Saladini D, Nafrialdi N, Dupont M, Mimran A. Effect of losartan and enalapril on renal adaptation to sodium restriction in rat. American Journal of Physiology 1994, 267 (Renal Fluid Electrolyte Physiology 36):F281-F288. Kupferman JC, Beaudoin R, Carr R, Hay D, Casellas D, Kaskel FJ, Moore LC. Activation of the renal renin-angiotensin system by Cyclosporine A and FK-506 in the rat. Transplant Proc 1994, 26: 2891-2893. Mimran A, Ribstein J, Du Cailar G, Halimi JM. Albuminuria in normals and essential hypertension. Journal of Diabetes and its complications 1994;8:150-156. Mimran A, Ribstein J, Du Cailar G. Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension ? Hypertension 1994, 23 (part 2):1018-1021. Mimran A, Ribstein J. Angiotensin-converting enzyme inhibitors versus calcium antagonists in the progression of renal diseases. American Journal of Hypertension 1994, 7:73S-81S. Mimran A. Renin-secreting tumours. In Textbook of Hypertension, Edited by JD Swales, Blackwell Scientific Publications 1994, p. 858-864. Moore LC, Rich A, Casellas D. Ascending myogenic autoregulation: Interactions between tubuloglomerular feedback and myogenic mechanisms. Bull Math Biol 1994, 56: 391-410. Nafrialdi N, Jover B, Mimran A. Endogenous vasoactive systems and the pressors effect of acute Nw-Nitro-L-Arginine Methyl ester administration. Journal of Cardiovascular Pharmacology 1994, 23:765-771. Pasquié JL, Jover B, Du Cailar G, Mimran A. Sodium but not chloride ion modulates left ventricular hypertrophy in two-kidney, one clip hypertension. Journal of Hypertension 1994, 12:1013-1018. Valentin JP, Ribstein J, Mimran A. Influence of Dopamine and Angiotensin II blockade on the acute response to unilateral nephrectomy in the rats. Journal of Cardiovascular Pharmacology 1994, 23:246-251.